Avail Scientific Signs Letter of Intent to Expand with Acquisition of Florida-Based Relai Neuro Neurological Testing Company

AVAIL SCIENTIFIC is thrilled to announce that it is taking an exciting step forward by entering into a letter of intent (LOI) to acquire Relai Neuro LLC, a Florida-based provider of neurological testing and data management services. This move will bring AVAIL SCIENTIFIC to the forefront of the neurological testing and data management industry.

Relai is doubling its sales force over the next three months and expanding its services into California, Texas, and Colorado with this acquisition – a move that will undoubtedly have a positive impact on the company’s operations. This is an exciting milestone for Relai as they continue to grow and provide an even better experience for their customers.

Dr. James Thompson, CEO of Relai Neuro, is thrilled to announce the acquisition of Avail Scientific. This strategic move will allow Relai to expand their offerings and team, as well as open up new potential markets in Florida, California, Texas, and Colorado. This acquisition is a major step forward for the company, and the team at Relai Neuro is excited to see the potential growth and success this will bring.

Avail’s goal of becoming a world leader in the clinically studied and supported use of psychedelic therapeutics for treatment of addiction & mental health issues is further accelerated through Relai Nero, which enables faster treatment application processing and data collection. According to Avail CEO Michael Paul, this cutting-edge tool will help them reach their ambitious goals.

Relai Neuro is revolutionizing the way rehab and mental health treatment centers in Florida provide neurological testing and data management. With cutting-edge technology, they are transforming the way treatment centers diagnose and monitor their patients, giving them the best possible care.

Relai is revolutionizing the way we measure progress in our neural functions. By utilizing their innovative products and methodology, they are able to directly measure the effects of treatments like Psilocybin micro-dosing in clinical environments. This is particularly exciting news for those suffering from addiction, as Relai is now providing a way to accurately track and measure the success of a treatment.

About Avail Scientific

Avail Scientific is driving a revolutionary change in the way we approach pharmacological therapies for addiction. Our evidence-based diagnostic and data acquisition programs offer preventative options as well as treatments, by targeting the root causes of substance abuse. Through our pioneering work, we are working to bring a medical and social revolution in the way we address addiction.

We are creating a platform that empowers healthcare professionals with the knowledge and tools they need to effectively treat medical conditions. Our mission is to develop and demonstrate rehabilitation and preventive therapy programs in collaboration with healthcare providers around the world. With our platform, we are striving to make a positive impact on patient outcomes.

Avail Scientific is on a mission to end the scourge of addiction and mental health issues worldwide by harnessing the power of data and patient monitoring to create evidence-based solutions that are proven to work. By leading the charge in this field, Avail Scientific is poised to revolutionize the way we address these difficult challenges.

Leave a Comment